Welcome to the Boehringer Ingelheim Pharmaceuticals Inc.(BIPI) and Lilly USA, LLC (Lilly) Alliance on-line application and grant management portal.
On January 11, 2011 BIPI and Lilly announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds. We are committed to supporting education that fosters innovative, high quality, independent medical education for healthcare professionals and patients that narrows unmet medical needs, maintains clinical excellence, and measurably improves health outcomes in areas of interest to the BIPI and Lilly Diabetes Alliance.
By agreement between BIPI and Lilly, grant requests will be processed through the BIPI on-line grant system but the application request will be reviewed by both companies. The following steps are required in order to process your grant request through our on-line grant management portal:
Medical Education Grants
A BIPI/Lilly medical education grant is designed to support independent medical education for healthcare providers and patients that may translate to better management of disease and improvement in patient safety and population health.
Please see below for submission timelines:
New and Returning Visitors to BIPI/Lilly Medical Grants
To begin a new application, return to a saved application, or track the status of an application already submitted login at https://bipisupport.envisionpharma.com/vt_bi/. If this is the first time you are visiting the site, you must register as a New User. An application ID beginning with "ME", will be assigned once you submit the application.
Educational Objectives - Diabetes
Educational Objectives – Alliance Biosimilars
Responding to a Request for Educational Grant Application (REGA)
Throughout the year, the Medical Grants department may announce a Request for Educational Grant Application (REGA). The intent of this announcement is to notify experienced and accredited Continuing Medical Education (CME) providers and accredited Continuing Education (CE) providers that BIPI/Lilly is interested in receiving applications for educational grants for support consideration.
Grant applications in response to BIPI/Lilly Alliance REGAs need to be submitted online at https://bipisupport.envisionpharma.com/vt_bi. While REGAs may specify timing of requested responses, BIPI and Lilly will continue to review all grant requests which are received.
To contact the BIPI/Lilly Alliance Medical Grants Department, please call (800) 295-0717. (8:00 a.m. - 5:00 p.m. EST, Monday – Friday)